Dataset Information


Necrosis related HIF-1alpha expression predicts prognosis in patients with endometrioid endometrial carcinoma.

ABSTRACT: Hypoxia inducible factor 1alpha (HIF-1alpha) plays an essential role in the adaptive response of cells to hypoxia and is associated with aggressive tumour behaviour. We have shown p27kip1, which is generally reduced in endometrial cancer, to be re-expressed in hypoxic regions. This possibly contributes to survival of cancer cells. The aim of this study was to evaluate the prognostic value of HIF-1alpha and p27kip expression in patients with endometrioid endometrial cancer.Expression levels of HIF-1alpha, CAIX, Glut-1, and p27kip1 were analyzed by immunohistochemistry. Percentage of positive cells, staining pattern (perinecrotic, diffuse, or mixed) and presence of necrosis were noted.Necrosis was correlated with shortened disease free survival (DFS) (p = 0.008) and overall survival (OS) (p = 0.045). For DFS, perinecrotic HIF-1alpha expression was also prognostic (p = 0.044). Moreover, high p27kip1 expression was an additional prognostic factor for these patients with perinecrotic HIF-1alpha expression. In multivariate Cox regression, perinecrotic HIF-expression emerged as an independent prognostic factor. Perinecrotic HIF-1alpha expression was significantly associated with CAIX and Glut-1 expression, pointing towards functional HIF-1.In patients with endometrioid endometrial cancer, necrosis and necrosis-related expression of HIF-1alpha are important prognostic factors. More aggressive adjuvant treatment might be necessary to improve the outcome of patients with these characteristics.


PROVIDER: S-EPMC2909981 | BioStudies | 2010-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC6033289 | BioStudies
2004-01-01 | S-EPMC480909 | BioStudies
2009-01-01 | S-EPMC2706285 | BioStudies
2013-01-01 | S-EPMC3568038 | BioStudies
1000-01-01 | S-EPMC2481565 | BioStudies
| S-EPMC2747505 | BioStudies
2009-01-01 | S-EPMC2795708 | BioStudies
2009-01-01 | S-EPMC2634728 | BioStudies
| S-EPMC2914555 | BioStudies
| S-EPMC3000903 | BioStudies